CR20230135A - Métodos para el tratamiento de enfermedades cardiovasculares con ciclodextrinas - Google Patents

Métodos para el tratamiento de enfermedades cardiovasculares con ciclodextrinas

Info

Publication number
CR20230135A
CR20230135A CR20230135A CR20230135A CR20230135A CR 20230135 A CR20230135 A CR 20230135A CR 20230135 A CR20230135 A CR 20230135A CR 20230135 A CR20230135 A CR 20230135A CR 20230135 A CR20230135 A CR 20230135A
Authority
CR
Costa Rica
Prior art keywords
disease
atherosclerosis
baseline
increase
level
Prior art date
Application number
CR20230135A
Other languages
English (en)
Spanish (es)
Inventor
Diana Kerwin
Jason Camm
Original Assignee
Beren Therapeutics P B C
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beren Therapeutics P B C filed Critical Beren Therapeutics P B C
Publication of CR20230135A publication Critical patent/CR20230135A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/724—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CR20230135A 2020-08-27 2021-08-27 Métodos para el tratamiento de enfermedades cardiovasculares con ciclodextrinas CR20230135A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063071257P 2020-08-27 2020-08-27
PCT/US2021/048084 WO2022047249A1 (en) 2020-08-27 2021-08-27 Methods for the treatment of cardiovascular disease with cyclodextrins

Publications (1)

Publication Number Publication Date
CR20230135A true CR20230135A (es) 2023-07-19

Family

ID=80353287

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20230135A CR20230135A (es) 2020-08-27 2021-08-27 Métodos para el tratamiento de enfermedades cardiovasculares con ciclodextrinas

Country Status (14)

Country Link
US (2) US20240000826A1 (cg-RX-API-DMAC10.html)
EP (1) EP4203974A4 (cg-RX-API-DMAC10.html)
JP (1) JP2023543131A (cg-RX-API-DMAC10.html)
KR (1) KR20230104119A (cg-RX-API-DMAC10.html)
CN (1) CN116322644A (cg-RX-API-DMAC10.html)
AU (1) AU2021331487A1 (cg-RX-API-DMAC10.html)
CA (1) CA3189915A1 (cg-RX-API-DMAC10.html)
CO (1) CO2023003656A2 (cg-RX-API-DMAC10.html)
CR (1) CR20230135A (cg-RX-API-DMAC10.html)
IL (1) IL300805A (cg-RX-API-DMAC10.html)
JO (1) JOP20230043A1 (cg-RX-API-DMAC10.html)
MX (1) MX2023002418A (cg-RX-API-DMAC10.html)
PE (1) PE20231169A1 (cg-RX-API-DMAC10.html)
WO (1) WO2022047249A1 (cg-RX-API-DMAC10.html)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4877778A (en) * 1987-07-01 1989-10-31 The Children's Medical Center Corporation Method of enhancing lipophile transport using cyclodextrin derivatives
WO2013155485A2 (en) * 2012-04-13 2013-10-17 Alessia Fornoni Method of using cyclodextrin

Also Published As

Publication number Publication date
EP4203974A1 (en) 2023-07-05
CA3189915A1 (en) 2022-03-03
IL300805A (en) 2023-04-01
CN116322644A (zh) 2023-06-23
KR20230104119A (ko) 2023-07-07
MX2023002418A (es) 2023-07-11
EP4203974A4 (en) 2024-08-07
JP2023543131A (ja) 2023-10-13
JOP20230043A1 (ar) 2023-02-27
CO2023003656A2 (es) 2023-08-09
AU2021331487A1 (en) 2023-03-16
WO2022047249A1 (en) 2022-03-03
US20240000826A1 (en) 2024-01-04
US20230091966A1 (en) 2023-03-23
PE20231169A1 (es) 2023-07-26

Similar Documents

Publication Publication Date Title
Aparicio-Trejo et al. Chronic impairment of mitochondrial bioenergetics and β-oxidation promotes experimental AKI-to-CKD transition induced by folic acid
Bell et al. The use of antiplatelet therapy in the outpatient setting: Canadian Cardiovascular Society guidelines
Chatrou et al. Vascular calcification: the price to pay for anticoagulation therapy with vitamin K-antagonists
Tibaut et al. Pathophysiology of myocardial infarction and acute management strategies
Tayebjee et al. Abnormal circulating levels of metalloprotease 9 and its tissue inhibitor 1 in angiographically proven peripheral arterial disease: relationship to disease severity
JOP20230130A1 (ar) أحماض بيرازولو بيبريدين كربوكسيليك تحمل بدائل
Sun Atherosclerosis and atheroma plaque rupture: normal anatomy of vasa vasorum and their role associated with atherosclerosis
MX2023002418A (es) Metodos para el tratamiento de enfermedades cardiovasculares con ciclodextrinas.
Daugherty et al. Recent highlights of ATVB: aneurysms
Cui et al. Atorvastatin reduces in vivo fibrin deposition and macrophage accumulation, and improves primary patency duration and maturation of murine arteriovenous fistula
Nyvad et al. With a little help from my friends: the role of the renal collateral circulation in atherosclerotic renovascular disease
Reza Khoshdel et al. Circulatory syndrome: an evolution of the metabolic syndrome concept!
EP2609925A3 (en) Dermatan sulfate for use in the treatment of pathologies wherein metalloproteinases are involved
Cohen et al. The safety of anticoagulant therapy in the treatment of splanchnic vein thrombosis associated with acute pancreatitis
Khan et al. Successful treatment of giant left subclavian artery pseudoaneurysm abutting the arch of the aorta and descending aorta
Khot et al. From congenital variants to critical clues: A radiologic review of inferior vena cava pathologies
Moore et al. Journal of Critical Limb Ischemia
Kola et al. Expert Recommendations on Antithrombotic Management of Peripheral Artery Disease: Perspectives from Indian Interventional Radiologists
Ali Hypertensive vascular disease
Komukai et al. Stent Failure due to Simultaneous Aggressive Neoatherosclerosis of First and Current Generation Drug Eluting Stents
Katikaneni et al. Antiphospholipid syndrome (APS)-an update on clinical features and treatment options
Pande et al. Complete resolution of extensive thrombosis of atheromatous non-aneurysmal descending aorta and pulmonary embolism with warfarin therapy
Evans et al. For personal use only
Vykoukal et al. Metabolic syndrome and outcomes after renal intervention
Salvi Arterial Stiffness in Chronic Kidney Disease